# Characteristics linked to mortality risk among individuals with drug use disorders enrolled in drug rehabilitation facilities in Japan

**Authors:** Satomi Mizuno, Takuya Shimane, Satoshi Inoura, Maki Kitamura, Toshihiko Matsumoto

PMC · DOI: 10.1002/pcn5.70112 · PCN Reports: Psychiatry and Clinical Neurosciences · 2025-05-15

## TL;DR

This study found that drug rehabilitation facilities in Japan are associated with high survival rates and reduced mortality risk for individuals with drug use disorders.

## Contribution

The study is the first to examine survival rates and mortality factors among individuals with drug use disorders in Japanese rehabilitation centers.

## Key findings

- The 5-year survival rate was 95.4% among participants.
- Age over 60 and bloodborne or sexually transmitted infections were linked to higher mortality.
- Abstinence was associated with reduced mortality risk.

## Abstract

This study evaluated survival rates and examined characteristics associated with mortality among individuals with drug use disorder (DUD) enrolled in drug addiction rehabilitation facilities in Japan.

This longitudinal cohort study, conducted from October 2016 to October 2021, followed 361 individuals with DUD residing in drug addiction rehabilitation centers nationwide. Participants had a mean age of 41.1 years (standard deviation 9.7) and most were men. About half had not completed high school or had criminal records, including drug offenses. Data were collected through eight follow‐up assessments conducted approximately every 6 months. Kaplan–Meier analysis was used to calculate 5‐year survival rates, and age‐specific mortality was evaluated among participants. A Cox proportional hazards model identified characteristics influencing mortality risk, including demographic factors, medical history, and abstinence maintenance. Hazard ratios and 95% confidence intervals were calculated to assess mortality risk.

The survival rate was 95.4%, with 14 deaths recorded. Mortality was highest among participants aged over 60 years. Age and the presence of bloodborne or sexually transmitted infections were significantly associated with higher mortality, while abstinence was associated with reduced mortality.

This study is the first to examine survival rates and mortality factors among individuals with DUD in drug addiction recovery centers in Japan. Findings suggest that these facilities may help prevent drug relapses and reduce mortality risk, while highlighting aging and infections as key factors linked to mortality.

Kaplan–Meier survival curve of facility users showing the estimated survival probability (solid line) over time.

## Linked entities

- **Diseases:** sexually transmitted infections (MONDO:0021681)

## Full-text entities

- **Diseases:** alcohol (MESH:D000437), mood disorders (MESH:D019964), addictions (MESH:D019966), developmental disorders (MESH:D002658), gaming disorders (MESH:C535406), chronic diseases (MESH:D002908), liver and cardiovascular diseases (MESH:D008107), eating disorders (MESH:D001068), syphilis (MESH:D013587), schizophrenia (MESH:D012559), gender identity disorder (MESH:D000068116), cognitive decline (MESH:D003072), accidents (MESH:D000081084), drug (MESH:D000081015), mental disorders (MESH:D001523), cardiovascular conditions (MESH:D002318), liver dysfunction (MESH:D017093), hepatitis (MESH:D056486), chlamydia, gonorrhea (MESH:D006069), neurological disorders (MESH:D009461), anxiety (MESH:D001007), Mental health disorders (OMIM:603663), HIV (MESH:D015658), diabetes (MESH:D003920), Bloodborne or sexually transmitted infection (MESH:D012749), poisoning (MESH:D011041), depression (MESH:D003866), cancer (MESH:D009369), Infections (MESH:D007239), infectious disease (MESH:D003141), pain (MESH:D010146), sexually (MESH:D050035), drug overdoses (MESH:D062787), gambling (MESH:D005715), Death (MESH:D003643)
- **Chemicals:** DARC (-), methamphetamine (MESH:D008694), cocaine (MESH:D003042), methylenedioxymethamphetamine (MESH:D018817), heroin (MESH:D003932), Alcohol (MESH:D000438)
- **Species:** Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12079023/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12079023/full.md

## References

84 references — full list in the complete paper: https://tomesphere.com/paper/PMC12079023/full.md

---
Source: https://tomesphere.com/paper/PMC12079023